We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Amgen, Allergan Announce Top-Line Results From Phase 3 Study

News   Jul 26, 2016

 
Amgen, Allergan Announce Top-Line Results From Phase 3 Study
 
 
 

RELATED ARTICLES

Gene Therapy for Life-limiting Blood Disorder Becomes Commercially Available

News

bluebird bio Inc. have announced that their gene therapy for the blood disorder transfusion-dependent β-thalassemia (TDT) is commercially available for the first time.

READ MORE

Diabetes Drug May Help To Prevent Miscarriage

News

According to a new study, an existing drug could be used to improve the womb for pregnancy in those who have had recurrent miscarriages.

READ MORE

Antipsychotic Meds Linked to Brain Injuries in Those With Alzheimer’s

News

A new study suggests that the use of antipsychotic medications is associated with an increased risk of head injuries in a study of individuals with Alzheimer’s disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE